Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001181431-10-035625
Filing Date
2010-07-01
Accepted
2010-07-01 19:52:49
Documents
1
Period of Report
2008-12-11

Document Format Files

Seq Description Document Type Size
1 FORM 3 rrd280150.html 3  
1 FORM 3 rrd280150.xml 3 2103
  Complete submission text file 0001181431-10-035625.txt   4021
Mailing Address 950 TOWER LANE SUITE 900 FOSTER CITY CA 94404-2125
Business Address 950 TOWER LANE SUITE 900 FOSTER CITY CA 94404-2125 650-358-3456
SCICLONE PHARMACEUTICALS INC (Issuer) CIK: 0000880771 (see all company filings)

EIN.: 943116852 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address VIALE SHAKESPEARE 47 ROME L6 00144
Business Address VIALE SHAKESPEARE 47 ROME L6 00144 011390659290443
APTAFIN S P A (Reporting) CIK: 0001232942 (see all company filings)

Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 000-19825 | Film No.: 10932261